Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation.
Both increased cell proliferation and apoptosis play important roles in the malignant growth of glioblastomas. We have demonstrated recently that the differential expression of protein kinase C (PKC)-eta increases the proliferative capacity of glioblastoma cells in culture; however, specific functions for this novel PKC isozyme in the regulation of apoptosis in these tumors has not been defined. In the present study of several glioblastoma cell lines, we investigated the role of PKC-eta in preventing UV- and gamma-irradiation-induced apoptosis and in caspase-dependent signaling pathways that mediate cell death. Exposure to UV or gamma irradiation killed 80% to 100% of PKC-eta-deficient nonneoplastic human astrocytes and U-1242 MG cells, but had little effect on the PKC-eta-expressing U-251 MG and U-373 MG cells. PKC-eta appears to mediate resistance to irradiation specifically such that when PKC-eta was stably expressed in U-1242 MG cells, more than 80% of these cells developed resistance to irradiation-induced apoptosis. Reducing PKC-eta expression by transient and stable expression of antisense PKC-eta in wild-type U-251 MG cells results in increased sensitivity to UV irradiation in a fashion similar to U-1242 MG cells and nonneoplastic astrocytes. Irradiation of PKC-eta-deficient glioblastoma cells resulted in the activation of caspase-9 and caspase-3, cleavage of poly (ADP-ribose) polymerase (PARP), and a substantial increase in subdiploid DNA content that did not occur in PKC-eta-expressing tumor cells. A specific inhibitor (Ac-DEVD-CHO) of caspase-3 blocked apoptosis in PKC-eta-deficient U-1242 MG cells. The data demonstrate that resistance to UV and gamma irradiation in glioblastoma cell lines is modified significantly by PKC-eta expression and that PKC-eta appears to block the apoptotic cascade at caspase-9 activation.
Hussaini
Isa M
IM
Department of Pathology, University of Virginia, Charlottesville 22908, USA.
Carpenter
Joan E
JE
Redpath
Gerard T
GT
Sando
Julianne J
JJ
Shaffrey
Mark E
ME
Vandenberg
Scott R
SR
D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001253:Astrocytes / Q000187:drug effects / Q000528:radiation effects; D053453:Caspase 9; D020169:Caspases / Q000378:metabolism*; D004396:Coloring Agents; D004247:DNA / Q000378:metabolism; D004789:Enzyme Activation / Q000528:radiation effects*; D005720:Gamma Rays; D005909:Glioblastoma / Q000503:physiopathology*; D006801:Humans; D007527:Isoenzymes / Q000172:deficiency / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D011419:Propidium; D011493:Protein Kinase C / Q000172:deficiency / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D013194:Staining and Labeling; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000528:radiation effects; D014466:Ultraviolet Rays
D004396:Coloring Agents; D007527:Isoenzymes; D011419:Propidium; D004247:DNA; C081975:protein kinase C eta; D011493:Protein Kinase C; C506433:CASP9 protein, human; D053453:Caspase 9; D020169:Caspases